Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 61 for “"pharma"”.
-
New SVP Pharma Plant in Argentina : análisis estratégico, económico y financiero
Pharmaceutical Argentina es una empresa de capitales alemanes que se radica en el país en la década del 90 para desarrollar actividades comerciales en el sistema de salud, con el objetivo de abastecer de un amplio portfolio de productos y servicios a los hospitales y centros de salud argentinos. …
-
DEVELOPMENT OF SUSTAINABLE AND EFFICIENT TAILOR-MADE PROCESSES FOR PHARMA AND FOOD APPLICATIONS
… of fine chemicals relevant for food and pharma applications which could be considered efficient and sustainable thanks to the employment of techniques with a low environmental impact (i.e., continuous synthesis, biocatalysis, new solvent systems). The main focus of this project was to …
-
'Pyrates' of the Lyceum: Big Pharma, Patents, and Academic Freedom in Neoliberal Times
… this brave new world and the intellectual pyscho-pharmacology and ideology of neoliberalism.
-
Assessing decision inputs in drug development between small, early stage companies and big pharma : is there is a difference?
… challenge facing large, publicly traded pharmaceutical companies, collectively referred to as "Big Pharma," is well known. The unprecedented success Big Pharma achieved over the past few decades in commercializing blockbuster products means that it is now faced with near-term patent …
-
Green supply chain management in the pharmaceutical sector: an investigation in the UK context
… barriers and green performance measures) in the pharmaceutical sector. It considers a synthesized understanding of Green Supply Chain Management practices in terms of Materials, Energy and Toxicity. This synthesized framework is used as a baseline to explore related green concepts and …
-
El programa de cambio: la transformación del equipo de liderazgo y su repercusión en resultados. El caso Delta Pharma Planta de Buenos Aires (2014-2017)
… cual se llamó por un nombre de fantasía “Delta Pharma”. Este estudio expuso las situaciones atravesadas por la planta en el período del 2014 al 2017 las cuales presentaron un gran desafío a la organización y requirieron implementar un nuevo paradigma para afrontar los cambios. Este fue un …
-
The role of finance and intangibles in the financialised pharmaceutical sector
… huge breakthroughs in high-tech sectors like pharmaceuticals. Meanwhile, these same sectors face intensified public scrutiny, over issues ranging from monopolisation to pricing, product safety, and more. The nature and institutional context of the contemporary pharmaceutical sector affords …
-
Evaluation und Erweiterung thermodynamischer Modelle zur Vorhersage von Wirkstofflöslichkeiten
… Mod. UNIFAC (Do), COSMO-RS(Ol), NRTL-SAC, Pharma Mod. UNIFAC). Die Anzahl an berechenbaren Löslichkeitsdaten hängt aufgrund modellspezifischer Parameter vom Aktivitätskoeffizientenmodell ab. Der Vergleich mit verfügbaren experimentellen Daten zeigt, dass sich die Modelle in ihrer …
-
Essays on Managing Healthcare Ecosystems
… transplantation and blood supply chains, to pharmaceutical innovation, research and development, and manufacturing and distribution, the healthcare ecosystem is wide ranging in both its functions and stakeholders. This dissertation aims to better understand, evaluate, and address major …
-
Regionale Innovations- und Kooperationsförderung mit Hilfe gesteuerter regionaler Kompetenznetzwerke - eine Untersuchung am Beispiel der Region Nürnberg
… der Untersuchung die Kompetenzinitiative Medizin-Pharma-Gesundheit (KIM) in Erlangen als Fallbeispiel herangezogen. Betreffend der Kooperationsförderung geben bei einer durchgeführten repräsentativen Akteursbefragung 96% der Antwortenden an, dass es für sie wichtig ist, mit anderen Akteuren …
-
Patient's willingness to pay for pharmaceutical care from community pharmacies in the north east of Thailand.
… and supply to encourage the implementation of pharmaceutical care through community pharmacies in NE Thailand. Objective - To determine i) the patient's willingness to pay (WTP) community pharmacists for defined pharmaceutical care, ii) factors which identify the WTP and iii) the feasibility of …
-
Að brúa bilið: Hvernig samræmist mannauðsstjórnun á milli fjölþjóðlegs móðurfélags og dótturfélags hér á landi?
… eigindlega og megindlega rannsókn innan Teva Pharma Iceland og Medis ehf. var reynt að meta skynjun starfsfólks á fjölþjóðlegri mannauðsstefnu, breytingarstjórnun, samskipti leiðtoga, laun, þjálfun og almennan stuðning frá mannauðsdeildum þessara fyrirtækja. Eigindlega rannsóknin fól í sér …
-
The evaluation of system-wide financial incentives in pipeline decisions in the pharmaceutical and biotechnology industry : the paradox of R&D spend Vs. new drug approvals
For several decades, the ascendancy of the Pharma & Biotech sector was largely driven by favorable macro-economic conditions combined with an astonishing level of innovation and a clear focus on addressing unmet medical needs. Significant R&D investments led to innovative drugs that changed …
-
Optimization of granule size and tablet properties in a twin screw granulator: the influence of process and formulation parameters
… 65) + polyethylene glycol (PEG) 4000, and the pharmaceutical formulation, α-D Lactose monohydrate + ibuprofen + PEG 4000 via a co-rotating granulator. Product characteristics (e.g., granule yield and strength, tablet crushing force, friability, and dissolution) are determined as being both …
-
What future physicians want : a comparative analysis of the perception of medical students and pharmaceutical industry executives regarding the future of pharmaceutical sales
The leading publicly traded pharmaceutical companies ("Big Pharma) in the US are facing a commercial crisis - their sales structure collectively consisting of more than 100,000 pharmaceutical sales representatives, originally setup to launch blockbusters, is suffering as a result of shrinking …
-
Implementation of the new FDA quality by design guidance in pharmaceutical production
… it is difficult to implement changes to a pharmaceutical process. Even small change request approvals can require months of effort for pharmaceutical companies and regulatory agencies. This resource intensive process discourages continuous improvement and often results in outdated and …
-
Patents and licensing and the commercialization of academic biomedical research
… research: universities, biotech firms, and big pharma. The Recombinant Capital database provided access to contracts for biomedical technology licensed from academe to biotech, and also subsequent contracts that included that same technology from biotech to big pharma. These two contracts …
-
Analyzing the relationship between capital structure and profitability of organizations: A case of the UK Pharmaceutical Industry
… in a congruent manner, the case study of the UK Pharma industry has been taken into consideration. As per the topic of the research, the UK markets in dire need to establish a confined relationship between the flexibility of the financial resources and the structure of the organisation. …
-
Deckschichtbildung in Kapillarmembranen bei der Querstrom-Mikrofiltration und ihre Beeinflussung durch polymere Flockungsmittel
… kommt zunehmend in den Bereichen Lebensmittel-, Pharma-, Chemieindustrie sowie in der Umwelttechnik zum Einsatz. Eine vollständige Beschreibung der Deckschichtbildung innerhalb der Membrananlage ist jedoch noch nicht gelungen. Der erste Teil dieser Arbeit widmet sich der Kuchenbildung in einer …
Page 1 of 4